RF (Radiofrequency) ablation effective as a first-line cancer treatment
This article was originally published in Clinica
Radiofrequency (RF) ablation may offer an alternative treatment option to liver cancer patients deemed inappropriate for surgery. This is the conclusion from two studies appearing in Radiology (March), which found the technique also extended patients' survival.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.